Morgan Stanley’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132M | Buy |
57,230,405
+5,196,704
| +10% | +$12M | 0.01% | 1131 |
|
|
2025
Q1 | $225M | Sell |
52,033,701
-4,204,010
| -7% | -$18.2M | 0.02% | 778 |
|
|
2024
Q4 | $107M | Buy |
56,237,711
+5,296
| +0% | +$10.1K | 0.01% | 1200 |
|
|
2024
Q3 | $221M | Sell |
56,232,415
-180,798
| -0.3% | -$711K | 0.02% | 775 |
|
|
2024
Q2 | $369M | Buy |
56,413,213
+1,815,090
| +3% | +$11.9M | 0.03% | 558 |
|
|
2024
Q1 | $333M | Sell |
54,598,123
-34,874,739
| -39% | -$213M | 0.03% | 591 |
|
|
2023
Q4 | $1.12B | Buy |
89,472,862
+44,653,484
| +100% | +$560M | 0.05% | 352 |
|
|
2023
Q3 | $796M | Buy |
44,819,378
+3,674,311
| +9% | +$65.3M | 0.08% | 238 |
|
|
2023
Q2 | $713M | Buy |
41,145,067
+4,527,489
| +12% | +$78.5M | 0.07% | 260 |
|
|
2023
Q1 | $870M | Sell |
36,617,578
-1,822,398
| -5% | -$43.3M | 0.09% | 219 |
|
|
2022
Q4 | $620M | Sell |
38,439,976
-2,631,010
| -6% | -$42.5M | 0.07% | 289 |
|
|
2022
Q3 | $962M | Sell |
41,070,986
-2,028,734
| -5% | -$47.5M | 0.13% | 159 |
|
|
2022
Q2 | $941M | Sell |
43,099,720
-1,273,368
| -3% | -$27.8M | 0.12% | 171 |
|
|
2022
Q1 | $1.12B | Buy |
44,373,088
+1,479,621
| +3% | +$37.5M | 0.15% | 150 |
|
|
2021
Q4 | $1.16B | Buy |
42,893,467
+35,062,024
| +448% | +$947M | 0.14% | 154 |
|
|
2021
Q3 | $205M | Buy |
7,831,443
+71,078
| +0.9% | +$1.86M | 0.03% | 522 |
|
|
2021
Q2 | $315M | Buy |
+7,760,365
| New | +$315M | 0.04% | 391 |
|